XML 32 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Business Combination (Tables)
9 Months Ended
Sep. 30, 2021
Business Combinations [Abstract]  
Schedule of Components of Purchase Price and Net Assets Acquired

The components of the purchase price and net assets acquired are as follows:

Purchase Price

Number of shares issued to Curetis N.V

2,028,208

Multiplied by the market value per share of OpGen's common stock (i)

$

2.39

Total fair value of common stock issued to Curetis N.V shareholders

4,847,417

Fair value of replacement stock awards related to pre combination service (ii)

136,912

Fair value of convertible notes assumed (iii)

1,323,750

Fair value of EIB debt assumed (iv)

15,784,892

Funds advanced to Curetis GmbH under Interim Facility

4,808,712

Cash and cash equivalents and restricted cash acquired

(1,266,849

)

$

25,634,834

 

 

(i)

The price per share of OpGen’s common stock was based on the closing price as reported on the Nasdaq Capital Market on April 1, 2020.

 

(ii)

The fair value of the stock options assumed was determined using the Black-Scholes option pricing model.

 

(iii)

To derive the fair value of the convertible notes, the Company estimated the fair value of the convertible notes with and without the derivative liability using a scenario analysis and Monte Carlo simulation.

 

(iv)

The fair value of the EIB debt is determined using a discounted cash flow analysis with current applicable rates for similar instruments.

Schedule of Net Assets Acquired

Net Assets Acquired

Assets acquired

Receivables

$

482,876

Inventory

2,022,577

Property and equipment

3,802,431

Right of use assets

1,090,812

Other current assets

925,364

Finite-lived intangible assets

Trade names/trademarks

1,768,000

Customer/distributor relationships

2,362,000

A50 - Developed technology

349,000

Ares - Developed technology

5,333,000

Indefinite-lived intangible assets

A30 - In-process research & development

5,706,000

Goodwill

6,688,652

Liabilities assumed

Accounts payable

(1,168,839

)

Accrued expenses and other current liabilities

(1,953,927

)

Derivative liabilities

(615,831

)

Lease liabilities

(1,108,193

)

Other long-term liabilities

(49,088

)

Net assets acquired

$

25,634,834

Schedule of Unaudited Pro Forma Results

The following unaudited pro forma financial information summarizes the results of operations for the periods indicated as if the Transaction had been completed as of January 1, 2020. Pro forma information primarily reflects adjustments relating to the amortization of intangibles acquired and elimination of interest expense due under the interim facility. The pro forma amounts do not purport to be indicative of the results that would have actually been obtained if the acquisition had occurred as of January 1, 2020 or that may be obtained in the future.

Unaudited pro forma results

 

Nine months ended

September 30, 2020

Revenues

$

3,886,834

Net loss

(22,340,822

)

Net loss per share

(1.59

)